RDHL - Redhill Biopharma Lt...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $6.31 | Open | $6.65 |
| Volume | 277.7K | Market Cap | 258.67M |
| Yield | Last Dividend |
| The Daily Biotech Pulse: FDA Authorizes ... | 05/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbV... | |
| RedHill Biopharma Provides Fourth Quarte... | 03/18/21 |
| TEL AVIV, Israel and RALEIGH, N.C., March 18, 2021 /PRNewswire/ -- Financials: Full year 2020 net revenues of approximately $64 million, with gross pr... | |
| RedHill Biopharma to Host Fourth Quarter... | 03/11/21 |
| TEL AVIV, Israel and RALEIGH, NC, March 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty bioph... | |
| RedHill to Present at Upcoming Conferenc... | 03/05/21 |
| TEL AVIV, Israel and RALEIGH, NC, March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopha... | |
| RedHill Biopharma Announces Closing of $... | 03/04/21 |
| TEL AVIV, Israel and RALEIGH, N.C., March 4, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Will stock surge befor... | 03/02/21 |
| RedHill Biopharma announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| ObvioHealth and RedHill Biopharma Launch... | 03/02/21 |
| NEW YORK, March 2, 2021 /PRNewswire/ -- ObvioHealth, a global virtual research organization or VRO, today announced the launch of a hybrid clinical tr... | |
| RedHill Biopharma Increases Previously A... | 03/02/21 |
| TEL AVIV, Israel and RALEIGH, NC, March 2, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopha... | |
| RedHill Biopharma Announces $10 Million ... | 03/01/21 |
| /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has... | |
| RedHill Biopharma Expands Opaganib Globa... | 02/23/21 |
| Following the FDA review of data from the U.S. Phase 2 study of opaganib and receipt of its recommendations, RedHill Biopharma Ltd (NASDAQ: RDHL) plan... | |
| The Daily Biotech Pulse: Aridis To Study... | 02/23/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22) Acc... | |
| RedHill Biopharma Strengthens Partnershi... | 02/18/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Feb. 18, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma to Present at SVB Leer... | 02/09/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Feb. 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty bioph... | |
| RedHill Biopharma Announces Positive DSM... | 01/29/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Increases Previously A... | 01/12/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 12, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Announces $10 Million ... | 01/11/21 |
| TEL AVIV, Israel and RALEIGH, N.C., Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill's Partner Cosmo Pharmaceuticals ... | 01/11/21 |
| TEL AVIV, Israel and RALEIGH, N.C,, Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biop... | |
| Biopharma Daily Stock Updates - 01/06/20 | 01/06/21 |
| $XBI $143.32 (+2.04%) ???? PIPELINE: $IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Dis... | |
| RedHill Biopharma's RHB-204 Granted FDA ... | 01/06/21 |
| TEL AVIV, Israel and RALEIGH, NC, Jan. 6, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biophar... | |
| RedHill Biopharma Ltd. said that prelimi... | 01/02/21 |
| RedHill Biopharma Ltd. said that preliminary data results from the US Phase 2 study of its opaganib administered in patients hospitalized with COVID-1... | |
| RedHill Biopharma Announces Positive Top... | 12/31/20 |
| It's what's happening in business. | |
| FXNEWS24 |Is the Options Market Predicti... | 12/28/20 |
| Is the Options Market Predicting a Spike in RedHill Biopharma (RDHL) Stock? | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex New... | |
| RedHill's Phase 2/3 COVID-19 Candidate O... | 12/15/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Dec. 15, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Extends Talicia?? Unre... | 12/07/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Dec. 7, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty bioph... | |
| RedHill Biopharma to Present at Evercore... | 11/23/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 23, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| RedHill Biopharma Initiates Phase 3 Stud... | 11/20/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 20, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biop... | |
| RedHill Announces Unanimous DSMB Recomme... | 11/19/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 19, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| Zacks Investment Research Lowers RedHill... | 11/18/20 |
| Zacks Investment Research downgraded shares of RedHill Biopharma (NASDAQ:RDHL) from a hold rating to a sell rating in a report released on Saturday, Z... | |
| RedHill Biopharma's Second COVID-19 Cand... | 11/17/20 |
| TEL AVIV, Israel and RALEIGH, N.C., Nov. 17, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biop... | |
| Date | 2021-03-18 (BMO) | Est. (EPS/Rev.) | ($0.24)/ 26.03M |
| Actual (EPS/Rev.) | $-0.07/ $21.46 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
